Literature DB >> 3519651

Effects of ketone bodies on basal and insulin-stimulated glucose utilization in man.

M Beylot, Y Khalfallah, J P Riou, R Cohen, S Normand, R Mornex.   

Abstract

Using the euglycemic clamp technique, we investigated the effects of high ketone body levels on basal and insulin-stimulated glucose utilization in normal subjects. Infusion of sodium acetoacetate in the postabsorptive state raised ketone body levels from 150 +/- 20 (+/- SE) mumol/liter to more than 1 mmol/liter. Endogenous glucose production declined from 2.71 +/- 0.20 mg kg-1 min-1 to 1.75 + 0.26 (P less than 0.01) and glucose utilization from 2.71 +/- 0.20 to 1.98 +/- 0.17 mg kg-1 min-1 (P less than 0.01), while blood glucose was maintained at the initial level by the infusion of glucose. There were no changes in plasma glucagon, insulin, or C-peptide. Plasma nonesterified fatty acids (P less than 0.01) and blood glycerol (P less than 0.01) and alanine (P less than 0.05) decreased, while blood lactate increased (P less than 0.01). Infusion of sodium bicarbonate had no effect on glucose kinetics. The decreases in glucose utilization and endogenous glucose production during the infusion of acetoacetate were not modified when the fall of plasma nonesterified fatty acids was prevented by iv heparin injection. During control euglycemic hyperinsulinemic clamps (1 and 10 mU kg-1 min-1 insulin infusion), endogenous glucose production was suppressed at the lowest insulin infusion rate; glucose utilization increased first to 7.32 +/- 0.96 mg kg-1 min-1 and then to 16.5 +/- 1.27 mg kg-1 min-1. During euglycemic hyperinsulinemic clamps with simultaneous sodium acetoacetate infusion, similar insulin levels were attained; endogenous glucose production was also suppressed at the lowest insulin infusion rate, and insulin-stimulated glucose utilization rates (7.93 +/- 1.70 and 15.80 +/- 1.30 mg kg-1 min-1) were not modified. In conclusion, acetoacetate infusion decreased basal, but not insulin-stimulated, glucose utilization. The increase in lactate during acetoacetate infusion in the postabsorptive state suggests that ketone body acted by decreasing pyruvate oxidation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519651     DOI: 10.1210/jcem-63-1-9

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion.

Authors:  B Beaufrère; M Beylot; C Metz; A Ruitton; R François; J P Riou; R Mornex
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

2.  A ketone monoester drink reduces the glycemic response to an oral glucose challenge in individuals with obesity: a randomized trial.

Authors:  Étienne Myette-Côté; Hannah G Caldwell; Philip N Ainslie; Kieran Clarke; Jonathan P Little
Journal:  Am J Clin Nutr       Date:  2019-12-01       Impact factor: 7.045

3.  Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man.

Authors:  K U Lee; H K Lee; C S Koh; H K Min
Journal:  Diabetologia       Date:  1988-05       Impact factor: 10.122

4.  Effect of nutritional status on insulin sensitivity in vivo and tissue enzyme activities in the rat.

Authors:  Y T Kruszynska; J G McCormack
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

5.  Intake of a Ketone Ester Drink during Recovery from Exercise Promotes mTORC1 Signaling but Not Glycogen Resynthesis in Human Muscle.

Authors:  Tijs Vandoorne; Stefan De Smet; Monique Ramaekers; Ruud Van Thienen; Katrien De Bock; Kieran Clarke; Peter Hespel
Journal:  Front Physiol       Date:  2017-05-23       Impact factor: 4.566

6.  Ketone Bodies and Exercise Performance: The Next Magic Bullet or Merely Hype?

Authors:  Philippe J M Pinckaers; Tyler A Churchward-Venne; David Bailey; Luc J C van Loon
Journal:  Sports Med       Date:  2017-03       Impact factor: 11.136

7.  Exogenous d-β-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis.

Authors:  Adrian Soto-Mota; Nicholas G Norwitz; Rhys D Evans; Kieran Clarke
Journal:  Endocrinol Diabetes Metab       Date:  2021-11-16

Review 8.  Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections.

Authors:  Brianna J Stubbs; Andrew P Koutnik; Emily L Goldberg; Vaibhav Upadhyay; Peter J Turnbaugh; Eric Verdin; John C Newman
Journal:  Med (N Y)       Date:  2020-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.